Royal Bank of Canada’s BioTime Inc Warrants (Expiring October 1, 2018) BTX.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-518
Closed 7185
2018
Q2
$0 Buy
518
+509
+5,656% +$38 ﹤0.01% 6988
2018
Q1
$0 Sell
9
-100
-92% -$15 ﹤0.01% 7145
2017
Q4
$0 Hold
109
﹤0.01% 7218
2017
Q3
$0 Buy
109
+50
+85% +$12 ﹤0.01% 7205
2017
Q2
$0 Buy
59
+9
+18% +$4 ﹤0.01% 6979
2017
Q1
$0 Hold
50
﹤0.01% 6966
2016
Q4
$0 Hold
50
﹤0.01% 6905
2016
Q3
$0 Sell
50
-162
-76% -$81 ﹤0.01% 6710
2016
Q2
$0 Hold
212
﹤0.01% 6662
2016
Q1
$0 Sell
212
-50
-19% -$34 ﹤0.01% 6854
2015
Q4
$0 Hold
262
﹤0.01% 6996
2015
Q3
$0 Hold
262
﹤0.01% 6889
2015
Q2
$0 Sell
262
-246
-48% -$472 ﹤0.01% 6821
2015
Q1
$1K Sell
508
-356
-41% -$477 ﹤0.01% 6027
2014
Q4
$1K Buy
+864
New +$937 ﹤0.01% 6086

Royal Bank of Canada's BTX.WS Position: Q3 2018 in Review

Royal Bank of Canada sold out of BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) in Q3 2018, closing a stake of 518 shares.

Royal Bank of Canada first reported a position in BTX.WS in Q4 2014 and held it in 15 quarters. The position peaked at $1K in Q1 2015. 7 funds tracked by Wall St. Rank hold BTX.WS as of Q3 2018.

  • Royal Bank of Canada reported no remaining BioTime Inc Warrants (Expiring October 1, 2018) position as of Q3 2018 after selling out during the quarter.
  • Royal Bank of Canada sold 518 BioTime Inc Warrants (Expiring October 1, 2018) shares in Q3 2018.
  • Royal Bank of Canada first reported a position in BioTime Inc Warrants (Expiring October 1, 2018) in Q4 2014 and held it in 15 quarters.
  • Royal Bank of Canada's BioTime Inc Warrants (Expiring October 1, 2018) position peaked at $1K in Q1 2015.
  • 7 funds tracked by Wall St. Rank held BioTime Inc Warrants (Expiring October 1, 2018) as of Q3 2018.

Based on Royal Bank of Canada's 13F filing for Q3 2018, filed 14 Nov 2018.